Literature DB >> 15589310

A functional autoantibody in narcolepsy.

Anthony J F Smith1, Michael W Jackson, Petra Neufing, R D McEvoy, Tom P Gordon.   

Abstract

Narcolepsy is widely believed to have an autoimmune basis, but conventional immunological approaches have failed to detect a serum autoantibody marker. Since cholinergic hyperactivity is a feature of narcolepsy-cataplexy, we transferred IgG from nine patients with narcolepsy and nine healthy controls to mice and assessed the effect on smooth muscle contractile responses to cholinergic stimulation. IgG from all narcolepsy patients significantly enhanced bladder contractile responses to the muscarinic agonist carbachol and to neuronally released acetylcholine compared with control IgG (p<0.0001), whereas contraction of the sympathetically innervated vas deferens was unaltered. Our findings provide direct evidence for the autoimmune hypothesis of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589310     DOI: 10.1016/S0140-6736(04)17553-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Furthering the understanding of the pathophysiology of narcolepsy.

Authors:  Michael J Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

3.  Immunoadsorption for the treatment of narcolepsy with cataplexy.

Authors:  Alessandro Pincherle; Flavio Villani; Luigi Ferini Strambi; Maria Livia Fantini; Suela Dylgjeri; Roberto Spreafico; Carlo Antozzi
Journal:  Neurol Sci       Date:  2008-12-05       Impact factor: 3.307

Review 4.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

5.  Genomewide association analysis of human narcolepsy and a new resistance gene.

Authors:  Minae Kawashima; Gen Tamiya; Akira Oka; Hirohiko Hohjoh; Takeo Juji; Takashi Ebisawa; Yutaka Honda; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Am J Hum Genet       Date:  2006-06-13       Impact factor: 11.025

Review 6.  Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets.

Authors:  Estelle T Spear; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

Review 7.  Genetic association, seasonal infections and autoimmune basis of narcolepsy.

Authors:  Abinav Kumar Singh; Josh Mahlios; Emmanuel Mignot
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

8.  Increased immune complexes of hypocretin autoantibodies in narcolepsy.

Authors:  Aude Deloumeau; Sophie Bayard; Quentin Coquerel; Pierre Déchelotte; Christine Bole-Feysot; Bertrand Carlander; Valérie Cochen De Cock; Sergueï O Fetissov; Yves Dauvilliers
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Francesca Poli; Christian Franceschini; Antonia Parmeggiani; Piero Pirazzoli; Filippo Bernardi; Emmanuel Mignot; Alessandro Cicognani; Pasquale Montagna
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

Review 10.  Etiopathogenesis and neurobiology of narcolepsy: a review.

Authors:  Swarup Kumar; Haritha Sagili
Journal:  J Clin Diagn Res       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.